// company-profile

Evommune, Inc.

EVMN
ExchangeNYSESectorPharmaceutical PreparationsInc.DEFilings44Insiders20
// api This Evommune, Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.

// activity-summary

Recent insider activity is bullish. Over the last 30 days, 3 insiders purchased shares. Buying was led by KIRSCH ARTHUR S.

// 90-day insight

Over the last 90 days, Evommune, Inc. insiders bought $0 across 9 transactions with no open-market sales.

  • Most active insider: Carver Kyle with 4 transactions totaling $460K.
  • Largest single sale: $415K by Carver Kyle on May 28, 2026.
  • 100% of recent sales were pre-scheduled 10b5-1 trades — typically less informative than open-market activity.

Activity skews bullish — buys outpace sales.

Institutional Ownership

Top 13F-HR holders of Evommune, Inc. as of 2026-03-31

↑ increasing
Total reported AUM
$730.3M
QoQ change
+62.5%
Reporting period
2026-03-31
#1
EQT Fund Management S.a r.l.
CIK 1834239
$113.3M
4.9M shares
#2
RA CAPITAL MANAGEMENT, L.P.
CIK 1346824
$80.3M
3.5M shares
#3
Pivotal bioVenture Partners Investment Advisor LLC
CIK 1844645
$44.3M
1.9M shares

Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Jun 2, 2026KIRSCH ARTHUR SEVMN
Award
15,673$0.00$0K
Jun 2, 2026Cohen David EEVMN
Award
15,673$0.00$0K
Jun 2, 2026MCGRAW BENJAMIN F IIIEVMN
Award
15,673$0.00$0K
Jun 2, 2026Cohen David EEVMN
Sale10b5
600$21.38$13K
Jun 2, 2026Cohen David EEVMN
Sale10b5
5,456$20.21$110K

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Popular companies on Form4API

Browse insider trading activity for other actively-filed companies.